In this article, we discuss 5 Best Stocks According to Clint Carlson’s Carlson Capital. If you want our detailed analysis of Carlson Capital’s history, investment philosophy, and hedge fund performance, go directly to 10 Best Stocks According to Clint Carlson’s Carlson Capital.
5. Duke Realty Corporation (NYSE:DRE)
Carlson Capital’s Stake Value: $49,455,000
Percentage of Carlson Capital’s 13F Portfolio: 3.39%
Number of Hedge Fund Holders: 25
Duke Realty Corporation (NYSE:DRE) owns and operates industrial assets totaling roughly 159 million rentable square feet in 20 global logistical regions. Securities filings for Q2 2022 reveal Duke Realty Corporation (NYSE:DRE) is a new addition to Clint Carlson’s Carlson Capital with 900,000 shares worth about $49.4 million, representing 3.39% of the portfolio.
According to Insider Monkey’s data, 25 hedge funds were long Duke Realty Corporation (NYSE:DRE) in Q2 2022, an increase from 18 funds in the last quarter. Alec Litowitz and Ross Laser’s Magnetar Capital is the largest stakeholder of the company with 1.9 million shares worth $108 million.
Here is what Baron Real Estate Income Fund has to say about Duke Realty Corporation (NYSE:DRE) in its Q2 2022 investor letter:
“Shares of Duke Realty Corporation, a $25 billion industrial REIT, declined only 7% in the second quarter, in large part because the company agreed to merge with Prologis at a 30% premium. We acquired additional shares in the company in the most recent quarter. We are optimistic about the prospects for the combined Prologis/Duke Realty entity. Prologis is merging with its largest REIT competitor in Duke Realty. Duke’s industrial portfolio is among the best in industrial real estate. The company has an excellent track record in development and construction. We believe the merger has strategic and financial merits including acquiring a high-quality portfolio in mostly similar or attractive real estate markets and the likelihood of realizing both additional revenue and cost savings. We will have more to say on Prologis/Duke Realty in future shareholder letters.”
4. Rogers Corporation (NYSE:ROG)
Carlson Capital’s Stake Value: $58,027,000
Percentage of Carlson Capital’s 13F Portfolio: 3.98%
Number of Hedge Fund Holders: 29
Rogers Corporation (NYSE:ROG) is a global company that designs, develops, produces, and distributes engineered materials and components. It works in three divisions: Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and other segments. Clint Carlson’s Carlson Capital increased its stake in Rogers Corporation (NYSE:ROG) by 43% by purchasing 221,400 shares worth around $58.02 million, representing 3.98% of the total holdings.
Among the hedge funds tracked by Insider Monkey, 29 funds were long Rogers Corporation (NYSE:ROG) at the end of Q2 2022, with combined stakes worth $631 million. Robert Emil Zoellner’s Alpine Associates is the leading position holder in the company, with 456,181 shares valued at around $119 million.
3. Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
Carlson Capital’s Stake Value: $74,312,000
Percentage of Carlson Capital’s 13F Portfolio: 5.1%
Number of Hedge Fund Holders: 58
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN), a clinical-stage biopharmaceutical business based in the United States, focuses on identifying and developing medicines for people suffering from severe neurological and neuropsychiatric illnesses. Clint Carlson’s Carlson Capital added Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) to its Q2 2022 porfolio by obtaining 510,000 shares valued at $74.31 million, representing 5.1% of the total 13F portfolio.
Among the hedge funds tracked by Insider Monkey, 58 funds were bullish on Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) at the end of June 2022, up from 41 funds in the prior quarter. Phill Gross And Robert Atchinson’s Adage Capital Management is the leading stakeholder of the company, with roughly 3.03 million shares worth $442 million.
Here is what Baron Health Care Fund has to say about Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) in their Q1 2021 investor letter:
“Biohaven Pharmaceutical Holding Company Ltd. is a biotechnology company dedicated to neurologic drug discovery. It launched its lead asset, migraine medication Nurtec, last year, and the company is transitioning towards profitability. Shares declined when Biohaven issued a secondary offering in March that took investors by surprise and seemed early in relation to an expected second indication for Nurtec in the prophylactic prevention of migraine, which expands its market. We exited our position.”
2. Alleghany Corporation (NYSE:Y)
Carlson Capital’s Stake Value: $75,812,000
Percentage of Carlson Capital’s 13F Portfolio: 5.21%
Number of Hedge Fund Holders: 38
Alleghany Corporation (NYSE:Y) offers property and liability reinsurance as well as insurance products in the United States and across the world. The corporation is divided into three divisions: Reinsurance, Insurance, and Alleghany capital. Carlson Capital, as of Q2 2022, owned 91,000 shares of Alleghany Corporation (NYSE:Y) worth $75.81 million, representing 5.21% of the total 13F holdings.
According to Insider Monkey’s data, 38 hedge funds were long Alleghany Corporation (NYSE:Y) in Q2 2022, with combined stakes worth $1.09 billion. Jean-Marie Eveillard’s First Eagle Investment Management is the major stakeholder of the company, with 427,205 shares worth around $355 million.
1. SWK Holdings Corporation (NASDAQ:SWKH)
Carlson Capital’s Stake Value: $158,868,000
Percentage of Carlson Capital’s 13F Portfolio: 10.91%
Number of Hedge Fund Holders: 3
SWK Holdings Corporation (NASDAQ:SWKH) is a healthcare-focused specialized finance firm. It is divided into two business units: Finance Receivables and Pharmaceutical Development. The company offers tailored finance solutions to a wide range of life science enterprises, including biotechnology, medical device, medical diagnostics and associated instruments, animal health, and pharmaceutical firms, as well as institutes and inventors.
Securities filings for Q2 2022 reveal that Carlson Capital owned 9.09 million shares of SWK Holdings Corporation (NASDAQ:SWKH) worth more than $158.86 million, representing 10.91% of the total 13F holdings.
Lake Street analyst Kyle Bauser on April 18 commenced coverage of SWK Holdings Corporation (NASDAQ:SWKH) with a Buy rating and a $26 price target.
According to Insider Monkey’s Q2 2022 data, there were 3 hedge funds bullish on SWK Holdings Corporation (NASDAQ:SWKH), with combined stakes valued at $175 million. J. Carlo Cannell’s Cannell Capital is one of the prominent holders of the company, having 943,236 shares worth $16.4 million.
You can also look at 10 Best Stocks to Buy According to Don Morgan’s Brigade Capital and Top 10 Stock Picks of Glenn Greenberg’s Brave Warrior Capital.
